| NO. | IPAD-DB ID | Name | Target-protein | Molecular Formula | 2D Structure | Ref. Link |
|---|---|---|---|---|---|---|
| 376 | D00376 | 2,2',4,4'-tetrabromodiphenyl ether | Aβ | C 1 2 H 6 B r 4 O |
|
|
| 377 | D00377 | REV-ERBβ | fAβ1-42 |
|
||
| 378 | D00378 | NeuroDefend | Aβ |
|
||
| 379 | D00379 | NeuroDefend | Tau protein |
|
||
| 380 | D00380 | REV-ERBα | fAβ1-42 |
|
||
| 381 | D00381 | N- (3- ((1S, 5S, 6S)-3-Amino-1- (methoxymethyl)-5methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl)-4, 5-difluorophenyl)-5- (prop-2-yn-1-yloxy)pyrazine-2-carboxamide （8） | Aβ40 |
|
||
| 382 | D00382 | EGFR inhibitor no. 3 | AR |
|
||
| 383 | D00383 | EGFR inhibitor no. 4 | AR |
|
||
| 384 | D00384 | EGFR inhibitor no. 3 | Htt |
|
||
| 385 | D00385 | EGFR inhibitor no. 4 | Htt |
|
||
| 386 | D00386 | Chronic nicotine | α-syn |
|
||
| 387 | D00387 | Nystalin | Aβ42 oligomers and fibrils |
|
||
| 388 | D00388 | Dengzhan Shengmai (DZSM) capsules | Aβ40 |
|
||
| 389 | D00389 | Dengzhan Shengmai (DZSM) capsules | Aβ42 |
|
||
| 390 | D00390 | Epi-2-inosose | Aβ40 |
|
||
| 391 | D00391 | Quetiapine | Aβ25-35 |
|
||
| 392 | D00392 | Pyrazinamide | Aβ42 | C 5 H 5 N 3 O |
|
|
| 393 | D00393 | Melatonin-N-benzylamine | Aβ |
|
||
| 394 | D00394 | 2,2',4,4'-tetrabromodiphenyl ether | Aβ | C 1 2 H 6 B r 4 O |
|
|
| 395 | D00395 | 2,2',4,4'-tetrabromodiphenyl ether | Aβ | C 1 2 H 6 B r 4 O |
|
|
| 396 | D00396 | 2,2',4,4'-tetrabromodiphenyl ether | Aβ | C 1 2 H 6 B r 4 O |
|
|
| 397 | D00397 | 2,2',4,4'-tetrabromodiphenyl ether | Aβ | C 1 2 H 6 B r 4 O |
|
|
| 398 | D00398 | 2,2',4,4'-tetrabromodiphenyl ether | Aβ | C 1 2 H 6 B r 4 O |
|
|
| 399 | D00399 | 2,2',4,4'-tetrabromodiphenyl ether | Aβ | C 1 2 H 6 B r 4 O |
|
|
| 400 | D00400 | 2,2',4,4'-tetrabromodiphenyl ether | Aβ | C 1 2 H 6 B r 4 O |
|